In the companion to this commentary in JCO Oncology Practice, Dima et al 1 provided a scholarly review on the diagnosis, increased awareness, and treatment of immunoglobulin light chain (AL) ...
MONTREAL — Levels of neurofilament light chain (Nfl) may be a biomarker of chemotherapy-induced peripheral neurotoxicity (PIPN), new research suggests. Investigators found Nfl levels increased in ...
Mortality trends (1999-2022) in patients with multiple myeloma with pneumonia, influenza, and COVID-19. Outcomes of myeloma cast nephropathy in the era of anti-CD38 monoclonal antibody-based frontline ...
Please provide your email address to receive an email when new articles are posted on . EMPHASIS study included 258 persons with MS given vidofludimus calcium or placebo for 24 weeks. Results show ...
The American Society of Hematology (ASH) released guidelines on the diagnosis of light chain (AL) amyloidosis, a rare and life-threatening disease of the bone marrow. The guidelines, published in the ...
Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues ...
On June 12th, 2023 local time, Sanyou Biopharmaceuticals Co., Ltd. officially announced the launch of "Sanyou Super Trillion Common Light Chain Antibody Discovery Platform" (the "platform"). As one of ...
Background: Diagnosis of monoclonal gammopathies (MGs) is determined by demonstration of a monoclonal immunoglobulin molecule or chain in serum and/or urine. Previous results on immunofixation ...
Elevate your neurological research from initial discovery to diagnostics through consistent measurement of neurofilament light (NfL). The Quanterix Simoa® NfL assay is a highly sensitive laboratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results